Articles published by Iantrek, Inc.

Iantrek Announces First Commercial Cases of its C.Rex Micro-Interventional System for Trabecular Outflow Enhancement

January 13, 2025

Iantrek Announces Peer-Reviewed Publication Highlighting 12-Month Safety and Effectiveness Results for its Bio-Interventional Uveoscleral Outflow Technology in Open-Angle Glaucoma Patients

December 10, 2024

From Iantrek, Inc.

Via GlobeNewswire

Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients

September 17, 2024

From Iantrek, Inc.

Via GlobeNewswire

Iantrek Announces Publication of Results of its Bio-interventional Uveoscleral Outflow Technology in Patients with Open-Angle Glaucoma

September 11, 2024

From Iantrek, Inc.

Via GlobeNewswire

Iantrek reports two upcoming American Academy of Ophthalmology presentations of its breakthrough glaucoma surgical technologies, including 1-year results of a novel supraciliary outflow micro-interventional procedure

October 16, 2023

From Iantrek, Inc.

Via GlobeNewswire

12-month clinical results of a novel micro-interventional bio-stenting procedure published in the British Journal of Ophthalmology

January 23, 2023

From Iantrek, Inc.

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.